[PDF][PDF] Diffusion-weighted magnetic resonance imaging in assessment of primary liver cancer after HIFU treatment
S Li, S Shi, A Li, H Liu, L Cai - J Coll Physicians Surg Pak, 2019 - jcpsp.pk
Objective: To determine the feasibility and role of diffusion-weighted magnetic resonance
imaging (DWI) in the assessment of high-intensity focused ultrasound (HIFU) for the …
imaging (DWI) in the assessment of high-intensity focused ultrasound (HIFU) for the …
Non-Cancerous Abnormalities That Could Mimic Prostate Cancer Like Signal in Multi-Parametric MRI Images
M Gaed - 2018 - search.proquest.com
Abstract Prostate Cancer (PCa) is the most common non-cutaneous cancer in North
American men. Multi-parametric magnatic resonance imaging (mpMRI) has the potential to …
American men. Multi-parametric magnatic resonance imaging (mpMRI) has the potential to …
[PDF][PDF] Improving Reproducibility and Efficiency of Interstitial HDR Brachytherapy Through MRI-based Targeted Innovations
A Shaaer - 2021 - rshare.library.torontomu.ca
Interstitial high dose rate (HDR) brachytherapy is a well-established treatment for prostate
and gynecological cancers. HDR brachytherapy involves delivery of a high dose of radiation …
and gynecological cancers. HDR brachytherapy involves delivery of a high dose of radiation …
[PDF][PDF] Novel multi-target nanoparticles contrast agent cooperated with MRI in early-stage prostate cancer
P Lv, F Ju, L Meng, J Xie, D Sun, T Yang… - … JOURNAL OF CLINICAL …, 2020 - e-century.us
Objective: To evaluate the application value of novel multi-target nanoparticles lenvatinib
contrast agent (lenvatinib) combined with magnetic resonance imaging (MTNCA-MRI) in …
contrast agent (lenvatinib) combined with magnetic resonance imaging (MTNCA-MRI) in …
Comparison of prostate cancer detection rates between the Vienna nomogram and the 10-core biopsy protocol
Objective: To compare the Vienna nomogram and the 10-core prostate biopsy protocol
regarding whether there is superiority in prostate cancer detection. Methods: Between …
regarding whether there is superiority in prostate cancer detection. Methods: Between …